 |
Seres Therapeutics
Last updated: September 13, 2024
Roger Pomerantz, CEO and President
USA | Funding: $537.8M (+)
Website: http://www.serestherapeutics.com/
Seres Therapeutics is creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis
Website: http://www.serestherapeutics.com/
Seres Therapeutics is creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis
